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Abstract: The use of different types of Newcastle disease (ND) vaccine in different vaccination schemes has decreased the incidence
of velogenic Newcastle disease (VND) in commercial poultry worldwide. In under-developed countries like Pakistan, these vaccination
schemes are not successful due to free-range and backyard poultry production.
This trial was conducted in 90 experimental chickens to develop an effective control against ND. The level of antibody response,
detected by haemagglutination-inhibition (HI) test, and the degree of protection against the virulent strain of Newcastle disease virus
(NDV) were studied. The chickens were immunized with commercially available ND vaccines. In scheme A, primary vaccination was
9
done with La Sota vaccine with 10 EID50, administered on day 5 by eye drop (E/D), followed by a booster vaccination with the same
vaccine and the same route on day 21 and, in scheme B, primary vaccination was done with the same vaccine (La Sota vaccine with
9
10 EID50), administered on day 5 by E/D, followed by a booster vaccination with a mesogenic strain (Mukteshwar) given
intramuscularly on day 21.
Both schemes of immunization conducted ensure comparatively solid immunity when challenged with a virulent field isolate of ND
at 6 weeks of age. A better protection index was obtained from chickens vaccinated with scheme B.
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Introduction
Newcastle disease (ND) is one of the most infectious,
highly contagious, fatal viral diseases of chickens,
characterized by respiratory, digestive, and nervous
symptoms as reported by Mishra et al. (1). According to
Gallili and Ben-Nathan (2), it is a worldwide problem with
severe economic implications, affecting chickens, turkeys,
and other birds. Alexander (3) stated that the morbidity
and mortality of susceptible birds may reach up to 100%
in the severe form of the disease, and unvaccinated birds
are more prone to the disease. Biosecurity and vaccination
are 2 important measures to address the problem and
have been used successfully for its prevention and control
for a long time as mentioned by Glisson and Kleven (4).
Chandraseker et al. (5) reported that vaccination protects
the birds by producing humoral and cell-mediated immune

responses. Both these responses are essential for
complete protection against infections. In chickens, live
vaccines administered by eye drop or orally have been
found to induce protective mucosal immunity mediated by
immunoglobulin (Ig)A antibodies as reported by
Jayawardane and Spradbrow (6), and Parry and Aitken
(7). On the other hand, Folitse et al. (8) found that
injected inactivated vaccines led to the production of high
levels of serum antibodies producing humoral immunity
that will protect the chicken against infection with the
virus. According to Van Eck (9), the disadvantage of
inactivated vaccines over live vaccines is that inactivated oil
emulsion vaccines do not induce local immunity in the
respiratory and digestive tracts; however, immunity is
established rather slowly. Killed vaccines are expensive
and difficult to administer than live vaccines.
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Many trials have been conducted to develop a single
annual vaccination program that can significantly control
ND and reduce the vaccination cost. In Pakistan various
vaccines are available commercially for the control of ND.
The objective of this study was to develop a vaccination
program that will improve the antibody response and will
give good protection against challenge with virulent virus.
The basic hypothesis of this study was that the efficacy of
a lentogenic strain (La Sota) vaccine could be improved by
subsequent administration of a mesogenic strain
(Mukteshwer) vaccine.

Materials and Methods
Chickens
One-day-old unvaccinated chicks were procured from
a local hatchery. They were brooded together for 5 days
in a disease-free animal house, until they were divided
into 3 groups. The unvaccinated control group was kept
in the same building where vaccinated birds were kept.
The birds received appropriate feeding and husbandry
throughout the experimental period.
Commercial Vaccines
A La Sota virus vaccine manufactured commercially
(Table 1) and a mesogenic vaccine (Mukteswar strain)
produced locally were procured. They were administered
according to the manufacturers’ instructions.
Challenge virus
A virulent field isolate of velogenic Newcastle disease
(VND) was selected that was previously characterized as
velogenic by the research workers in the Department of
Microbiology, University of Veterinary and Animal
5.5
Sciences, Lahore. Concentration of the virus was 10
LD50 and the challenge dose was 0.1 ml (100 × LD50) per
bird.

Experimental design
The experimental design is given in Table 1. The
experiment lasted 62 days. On day 1, 90 chicks were
randomly divided into 3 groups, named 1, 2, and 3,
comprising 30 chicks each and bled for pre-vaccination
sera. Groups 1 and 2 were vaccinated according to the 2
vaccination schemes mentioned in Table 1. Group 3 was
kept as an unvaccinated control.
Sampling Schedule
Ten randomly selected birds from each group having
the same maternal antibody titer were taken. Blood
samples from these birds were collected on days 1, 5, 14,
21, 34, 42, 54, and 61. Sera were separated and stored
at –20 °C until further use.
Challenge with virulent field virus
Twenty birds from each group were isolated and
challenged on day 42 with velogenic NDV at a dose rate
of 0.1 ml per bird administered subcutaneously. The
birds were kept under observation for 19 days for the
development of clinical signs of the disease or mortality.
Postmortem examination of the dead birds was done,
lesions (if any) were recorded, and samples were
collected for the re-isolation of the causative agent.
Numbers of dead and live birds were recorded. The
preventable fraction/protection index to evaluate the
efficacy of vaccines was calculated as described by Tizard
(10).
Determination of lethal dose (LD50) of Newcastle
disease virus (NDV)
To calculate LD50, 25 cockerels (28-days old) were
procured and divided into 5 groups, namely A1, A2, A3, A4,
and A5. Each bird in group A1 was injected intramuscularly
with 0.2 ml of 10-2 concentration of NDV. Groups A2

Table 1. Experimental design.
Vaccination
Day of vaccination

Scheme A

Scheme B

5

TAD ND Vac La Sota with 109 EID50 (E/D)

TAD ND Vac La Sota with 109 EID50 (E/D)

12

IBD (S/C)

IBD (S/C)

17

HPS (S/C)

21

166

HPS (S/C)
9

TAD ND Vac La Sota with 10 EID50 (E/D)

Mukteswar (I/M)
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Table 2. Geometric mean titer (GMT) in chickens vaccinated with ND vaccines.
HI GMT before infection on day:

HI GMT after challenge on day:

Groups
Day 5

Day 14

Day 21

Day 34

Day 42

Day 54

Day 61

1

22.60

137.20

55.70

168.90

32.00

4.60

7.50

2

22.60

128.00

64.00

68.60

8.00

6.10

4.60

3

22.60

4.30

2.50

1.20

13.00

48.20

128.00

Table 3. Protection against challenge with virulent field strain of NDV.
Groups

Total birds

Live birds

Dead birds

Mortality (%)

Preventable
fraction/protection Index

1

20

17

03

15

75

2

20

20

00

00

100

3

20

08

12

60

-

through A5 were inoculated with 0.2 ml of concentration
10-3, 10-4, 10-5 and 10-6, respectively. Birds in all the
groups were observed for mortality up to 10 days postinoculation. The LD50 of the virus was determined as
described by Reed and Muench (11).
Experimental Parameters
The following parameters were studied:

Antibody titer against NDV:
Antibody titer against NDV in serum was determined
by haemagglutination inhibition (HI) test as described by
Allan and Gough (12).

Post-challenge mortality:
Post-challenge mortality in chicks of all groups was
recorded. A postmortem examination of the dead birds
was performed and lesions (if any) were recorded.
Statistical analysis of results
The level of antibody response was analyzed and
compared between groups 1 and 2 by using a 2-sample
t-test for equal variance as described by Steel and Torrie
(13). Significance level was P < 0.05.

Results
The antibody response of the chickens to vaccination
schemes and resistance to virulent field virus challenge
are given in Tables 2 and 3, respectively. After vaccination
HI geometric mean titer (GMT) values were determined
and it was observed that on day 14 these values increased
significantly in both groups (137.00 in group 1 and
128.00 in group 2).
After the booster vaccination, the HI GMT values were
recorded as 168.90 in group 1 and 68.60 in group 2 on
day 34. The HI GMT values were statistically analyzed and
the difference between them was non-significant (P <
0.05). The antibody titers decreased gradually after the
challenge (day 42) and they were recorded as 7.50 in
group 1 and 4.60 in group 2 on day 61. Birds that
survived in the control group showed increasing levels of
HI GMT, i.e. 128.00 on day 61.
After the challenge, in group 1 the vaccination scheme
gave 75% protection and in group 2 it gave 100%
protection. Unvaccinated control birds were highly
susceptible to challenge; 12 deaths were recorded. The
birds that died post-challenge were examined for any
postmortem changes. Usually gross lesions were minimal
167
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in young or old birds although there were mild air
sacculitis, conjunctivitis, and tracheitis. The other changes
observed were haemorrhagic or necrotic focal lesions,
present in the mucosa of the intestine.

Discussion
Despite the widespread use of different types of
vaccines, ND continues to be a major threat to the poultry
industry. Comparative efficacy of commercially available
vaccines has been a challenge for scientists. The present
study evaluated 2 vaccination schemes for the
commercially available live vaccines against NDV to be
used under local conditions. The 2 vaccination schemes
used in this study include scheme A, in which La Sota
(lentogenic) vaccine was administered via eye drop at day
5 of age followed by a booster vaccination with the same
vaccine on day 21 of age in broilers, compared with a
booster vaccination with a mesogenic vaccine, i.e.
Mukhteswar, by i/m route in scheme B.
A number of researchers have reported that live ND
vaccines give better protection and health status than
killed vaccines (14,15). The use of live vaccines is
preferred for priming the birds as it produces local
immunity in the mucosal membrane of the conjunctiva,
thus providing immediate protection on subsequent
exposure with field virus challenge. Folitse et al. (8) also
observed that live vaccines induce local immunity followed
by inactivated vaccine, which causes slow release of
antibodies. Parry and Aitken (7) also found that live ND
vaccines administered by eye drop or orally induce
protective mucosal immunity mediated by IgA antibodies.
It is speculated that the results obtained in our study
indicate that the high antibody titer in group 1 on day 34
is due to the booster vaccination (day 21) with La Sota
virus, which replicated quickly in the mucosal membrane
of the conjunctiva, inducing local immunity.
It is advisable that priming of the birds should be
carried out when the maternal antibody titer drops to the
level where it does not interfere with the vaccine. In the
current study, the initial vaccination was carried out at
the time when the maternal antibody titer (GMT 128)
was diminishing (GMT 22.60).
Alexander (3) reported that live lentogenic NDV
4
6
vaccines produce an antibody titer of 2 to 2 . However,
higher HI titers (as high as 211 or more) may be obtained
following a vaccination program involving oil-emulsion
168

vaccines. Westbury et al. (16) also observed that La Sota
is much more immunogenic than the Hitchner B1 and
strain V4. Giambrone (17) conducted an experiment to
evaluate a ND vaccination program and reported that
NDV HI titers were highest and resistance to challenge is
greatest in birds initially vaccinated at day 1 with a live
vaccine by coarse spray and then revaccinated at day 14
by the same vaccine by the same route. The increase in
antibody titers recorded after the primary vaccination
(GMT 137.00 in group 1 and 128.00 in group 2) in the
present study is in agreement with these observations.
According to Alexander (3), the actual titers obtained
and their relationship to the degree and duration of
immunity for any given program are difficult to predict.
In the current study antibody titers in group 2 were also
unpredictable. The drop in HI titers (GMT 68.60) after
the booster vaccination is speculated to be due to the
intramuscular injection of the mesogenic strain of NDV
(Mukteshwer), which induced a secondary immune
response, but the antibodies circulating in the serum,
which are detectable by HI test, were low in number.
These low-HI detecting antibodies provide immunity and
protection to chickens up to 41 days post-vaccination.
A post-challenge decrease in HI antibody titer was
observed in birds receiving vaccination as compared to
the non-vaccinated control, in which the HI antibody titer
was increased. These findings are in line with the findings
reported by Tizard (18), which showed that antibody
titer was decreased due to neutralization of the virus by
circulating antibodies.
On the basis of post-challenge mortality, group 2
showed 0% mortality against challenge with NDV as
compared to group 1. This indicates that birds initially
vaccinated with La Sota (with 109 EID50) and revaccinated
with Mukteswar strains had 100% protection, although
HI antibodies titers were low. Therefore, it is speculated
that, in addition to the protection by HI antibodies, other
mechanisms of protection apparently played a part.
Lower mortality in La Sota vaccinated birds followed by
inactivated NDV was also reported by Mrzel et al. (19).
These results are also consistent with the findings
reported by Winterfield et al. (20). Khadzhiev et al. (21)
also found that, out of 4 vaccination schemes, better
production index results were obtained from birds
vaccinated with La Sota by the spray method followed by
Komarov (mesogenic) strain given intramuscularly.
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From the above discussion it can be concluded that a
vaccination scheme having La Sota (with 109 EID50) as
primary vaccine followed by Mukteswar strain vaccines
had more protective effects on the host than La Sota
(with 109 EID50) alone. No significant differences were
observed in the HI antibody titer between La Sota (with

109 EID50) followed by Mukteshwer and La Sota (with
109 EID50) alone vaccines, but a significant difference was
found between the protective index of schemes A and B.
Therefore, scheme B can be recommended for an
effective ND control program under local conditions
(Pakistan).
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